Real-Time RT Planning, Delivery in the Bronx

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 15 No 7
Volume 15
Issue 7

Montefiore Medical Center has opened a state-of-the-art Center for Radiation Therapy within walking distance of the Montefiore-Einstein Cancer Center. The new 15,000 square foot, two-story radiation therapy center is part of the burgeoning facilities located in the Morris Park campus, which services the approximately 1.25 million residents of the Bronx.

BRONX, New York—Montefiore Medical Center has opened a state-of-the-art Center for Radiation Therapy within walking distance of the Montefiore-Einstein Cancer Center. The new 15,000 square foot, two-story radiation therapy center is part of the burgeoning facilities located in the Morris Park campus, which services the approximately 1.25 million residents of the Bronx.

The radiation center is the first in New York to offer image-guided intensity modulated radiation therapy (IG-IMRT) via Varian Medical Systems' Trilogy system, which introduces a fourth dimension—time—into treatment planning and execution. The on-board imaging system incorporated into the Trilogy unit allows the radiologist to verify patient setup immediately prior to treatment. The system produces a three-dimensional (3D) movie loop of the tumor as it moves with the patient's breathing. Functional and metabolic information about tumor aggressiveness is integrated into images of tumor shape and size.

"For example," said Shalom Kalnicki, MD, chairman of the Department of Radiation Oncology at Montefiore, "the 3D motion of a lung tumor can be seen and analyzed in real time while the patient is breathing, allowing the radiation oncology team to produce a precise beam that closely follows the tumor's motion."

A respiratory gating system monitors respiratory motion during treatment delivery. "For cancers of organs that move with respiration, image-guided radiotherapy produces a beam that precisely follows tumor motion and sculpts highly focused radiation around it," he said.

At the core of the Trilogy system is a high-powered medical linear accelerator (see photo) that rotates around the patient to deliver radiation treatment from various angles and that incorporates a multileaf collimator to shape the radiation beam to match the 3D shape of the tumor.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Specialties including neurosurgery, radiation oncology, and neuro-rehabilitation all play a notable role in the care of patients with brain tumors.
Treatment-related toxicities during neuro-oncology therapy appear well managed with dose modifications and treatment cycle holds.
The phase 3 NIVOSTOP trial evaluated an anti–PD-1 immunotherapy, nivolumab, in a patient population similar in the KEYNOTE-689 trial.
CAR T-cell therapies appear to be an evolving modality in the treatment of those with intracranial tumors, said Sylvia Kurz, MD, PhD.
Opportunities to further reduce relapses include pembrolizumab-based combination therapy and evaluating the agent’s contribution before and after surgery.
For patients with locally advanced head and neck cancers, the current standard of care for curative therapy has a cure rate of less than 50%.
According to Maurie Markman, MD, patient-reported outcomes pertain to more relevant questions surrounding the impact of therapy for patients.
CancerNetwork® spoke with Neha Mehta-Shah, MD, MSCI, about the clinical landscape for patients undergoing treatment for rare lymphomas.
Related Content